In the dynamic world of life sciences, companies face unique challenges in safeguarding their valuable assets. From ...

Despite recent staffing reductions and leadership transitions at the FDA, pharmaceutical and medical device manufacturers ...

Professor David Jones, Professor of Pharmaceutical and Biomaterial Engineering from the School of Pharmacy at Queen’s ...

An Enquirer analysis found that doctors, nurses and other practitioners received $136 million from pharma and biotech ...

Mount Marty University will launch the region’s first Graduate Regulatory Science Program to train future leaders in the ...

High-end medical devices, including those made in the United States, may be especially vulnerable to tariffs because they’re ...

A series of tariffs recently implemented could have significant implications for health care. A large proportion of medical ...

Innolitics specializes in medical device software development ... of what we believe represents a significant shift in the pharmaceutical industry. We believe that our $10 million cash position ...

Pharma Equity Group (PEG) is a dynamic life sciences investment and development firm listed on the Nasdaq Copenhagen stock exchange. PEG is dedicated to identifying, acquiring, and advancing ...

Abbott boasts strong profitability, stable margins, and impressive long-term growth, but recent sales have stagnated. Check ...

Uttar Pradesh's pharma sector attracted ₹2,845 crore investment, creating 70,000+ jobs in three years, aided by the Nivesh ...

1. Data protection periods of 6 years, 3 years and 3 years are set for innovative drugs, improved new drugs and first generic ...